glucagon like peptide 1 glp 1 Frontiers Cardiovascular Effects of Glucagon-Like Peptide-1

#### Indications: **Vitamin B12 Deficiency:** Treatment of vitamin B12 deficiency due to malabsorption, dietary insufficiency, or increased physiological needs (e.g., pregnancy, lactation)

Semaglutide still the GLP-1 heavyweight If Novo Nordisks semaglutide were counted as a single drug, it would be second bestselling drug of 2023, with total sales of $19.93 billion compared to Keytrudas (pembrolizumab) $25.01 billion

They are effective for weight loss and type 2 diabetes

These cases require a thorough investigation into the specific compound, its ingredients, and the circumstances of its prescription and use